Description
BSE announces listing of 2,96,296 new equity shares of Vivo Bio tech Ltd. from July 28, 2025, issued through warrant conversion.
Summary
BSE has announced the listing of 2,96,296 new equity shares of Vivo Bio tech Ltd. (Scrip Code: 511509) effective from Monday, July 28, 2025. These shares were issued at a premium of Rs. 35/- per share to non-promoters on a preferential basis pursuant to conversion of warrants, with an issue price of Rs. 45/- per share.
Key Points
- 2,96,296 new equity shares of Rs. 10/- each listed
- Shares issued to non-promoters through warrant conversion
- Issue price: Rs. 45/- per share (Rs. 10/- face value + Rs. 35/- premium)
- Distribution numbers: 16868521 to 17164816
- Shares rank pari-passu with existing equity shares
- ISIN: INE380K01017
Regulatory Changes
No regulatory changes announced - this is a standard listing notification for new securities.
Compliance Requirements
Trading members are informed that these new securities are permitted for trading on the exchange from the effective date.
Important Dates
- Allotment Date: March 29, 2025
- Trading Commencement: July 28, 2025
- Lock-in Period End: February 28, 2026
Impact Assessment
This is a routine listing with minimal market impact. The addition of 2,96,296 shares represents a small increase in the company’s traded shares. The lock-in period until February 2026 ensures these shares cannot be traded immediately, limiting any potential dilution impact on existing shareholders.
Impact Justification
Routine listing of new shares through warrant conversion with standard lock-in provisions